Roche Signs US$2 B Partnership with Monte Rosa for Molecular Glue Medicines
By Amit Kaushik
Pharma Deals Review: Vol 2023 Issue 10 (Table of Contents)
Published: 30 Oct-2023
DOI: 10.3833/pdr.v2023.i10.2829 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
In yet another deal to diversify its portfolio, Roche has entered into a licensing and collaboration agreement with Monte Rosa Therapeutics to develop small molecule-based therapeutics for challenging targets in major disease areas, including oncology and neurodegeneration...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS